WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013

Feb 21, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-02-19

Reporting Person: Flynn Karen (President, America's Region)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-19	Common Stock	A	682.0000	$59.1100	Acquired	4531.0974	Direct
2013-02-19	Common Stock	A	566.0000	$59.1100	Acquired	5097.0974	Direct
2013-02-19	Common Stock	A	271.0000	$5911.0000	Acquired	281.8226	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-19	Stock Option (Right to Buy)	$59.1100	A	13169.0000	Acquired	2023-02-19	Common Stock (13169.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	155.8650	Indirect

Footnotes

F1: Bonus and incentive shares granted on 02/19/2013.

F2: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2010 that have vested for performance period 9.